Overview
Taro Ozaki practices practicing medicine in Sendai, Japan.
His clinical expertise encompasses Anti-NMDA Receptor Encephalitis.
He is actively involved in clinical research, co-authoring 69 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Taro Ozaki
Is Taro Ozaki a top-rated expert for Anti-NMDA Receptor Encephalitis?
MediFind is an objective health platform that identifies experts based on real-world data. Taro Ozaki is classified as an Experienced expert for Anti-NMDA Receptor Encephalitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Taro Ozaki participate in research or clinical trials?
Yes. Taro Ozaki has published 69 articles and abstracts on conditions like Anti-NMDA Receptor Encephalitis. You can view a list of Taro Ozaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anti-NMDA Receptor EncephalitisMr. Ozaki isExperienced. Learn about Anti-NMDA Receptor Encephalitis.